Works by Palandri, Francesca

Results: 116
    1

    Incidence of blast phase in myelofibrosis according to anemia severity.

    Published in:
    EJHaem, 2023, v. 4, n. 3, p. 679, doi. 10.1002/jha2.745
    By:
    • Mora, Barbara;
    • Maffioli, Margherita;
    • Rumi, Elisa;
    • Guglielmelli, Paola;
    • Caramella, Marianna;
    • Kuykendall, Andrew;
    • Palandri, Francesca;
    • Iurlo, Alessandra;
    • De Stefano, Valerio;
    • Kiladjian, Jean‐Jacques;
    • Elli, Elena M.;
    • Polverelli, Nicola;
    • Gotlib, Jason;
    • Albano, Francesco;
    • Silver, Richard T.;
    • Benevolo, Giulia;
    • Ross, David M.;
    • Devos, Timothy;
    • Borsani, Oscar;
    • Barbui, Tiziano
    Publication type:
    Article
    2
    3
    4
    5

    Association of Platelet Thromboxane Inhibition by Low‐Dose Aspirin With Platelet Count and Cytoreductive Therapy in Essential Thrombocythemia.

    Published in:
    Clinical Pharmacology & Therapeutics, 2022, v. 111, n. 4, p. 939, doi. 10.1002/cpt.2485
    By:
    • Tosetto, Alberto;
    • Rocca, Bianca;
    • Petrucci, Giovanna;
    • Betti, Silvia;
    • Soldati, Denise;
    • Rossi, Elena;
    • Timillero, Andrea;
    • Cavalca, Viviana;
    • Porro, Benedetta;
    • Iurlo, Alessandra;
    • Cattaneo, Daniele;
    • Bucelli, Cristina;
    • Dragani, Alfredo;
    • Di Ianni, Mauro;
    • Ranalli, Paola;
    • Palandri, Francesca;
    • Vianelli, Nicola;
    • Beggiato, Eloise;
    • Lanzarone, Giuseppe;
    • Ruggeri, Marco
    Publication type:
    Article
    6

    Long‐term pharmacodynamic and clinical effects of twice‐ versus once‐daily low‐dose aspirin in essential thrombocythemia: The ARES trial.

    Published in:
    American Journal of Hematology, 2024, v. 99, n. 8, p. 1462, doi. 10.1002/ajh.27418
    By:
    • Rocca, Bianca;
    • Tosetto, Alberto;
    • Petrucci, Giovanna;
    • Rossi, Elena;
    • Betti, Silvia;
    • Soldati, Denise;
    • Iurlo, Alessandra;
    • Cattaneo, Daniele;
    • Bucelli, Cristina;
    • Dragani, Alfredo;
    • Di Ianni, Mauro;
    • Ranalli, Paola;
    • Palandri, Francesca;
    • Vianelli, Nicola;
    • Beggiato, Eloise;
    • Lanzarone, Giuseppe;
    • Ruggeri, Marco;
    • Carli, Giuseppe;
    • Elli, Elena Maria;
    • Renso, Rossella
    Publication type:
    Article
    7

    Determinants of early triage for hospitalization in myeloproliferative neoplasm (MPN) patients with COVID‐19.

    Published in:
    American Journal of Hematology, 2022, v. 97, n. 12, p. E470, doi. 10.1002/ajh.26732
    By:
    • Barbui, Tiziano;
    • Carobbio, Alessandra;
    • Ghirardi, Arianna;
    • Iurlo, Alessandra;
    • Sobas, Marta Anna;
    • Elli, Elena Maria;
    • Rumi, Elisa;
    • De Stefano, Valerio;
    • Lunghi, Francesca;
    • Marchetti, Monia;
    • Daffini, Rosa;
    • Gasior Kabat, Mercedes;
    • Cuevas, Beatriz;
    • Fox, Maria Laura;
    • Andrade‐Campos, Marcio Miguel;
    • Palandri, Francesca;
    • Guglielmelli, Paola;
    • Benevolo, Giulia;
    • Harrison, Claire;
    • Foncillas, Maria‐Angeles
    Publication type:
    Article
    8

    Second cancers in MPN: Survival analysis from an international study.

    Published in:
    American Journal of Hematology, 2020, v. 95, n. 3, p. 295, doi. 10.1002/ajh.25700
    By:
    • Marchetti, Monia;
    • Ghirardi, Arianna;
    • Masciulli, Arianna;
    • Carobbio, Alessandra;
    • Palandri, Francesca;
    • Vianelli, Nicola;
    • Rossi, Elena;
    • Betti, Silvia;
    • Di Veroli, Ambra;
    • Iurlo, Alessandra;
    • Cattaneo, Daniele;
    • Finazzi, Guido;
    • Bonifacio, Massimiliano;
    • Scaffidi, Luigi;
    • Patriarca, Andrea;
    • Rumi, Elisa;
    • Casetti, Ilaria Carola;
    • Stephenson, Clemency;
    • Guglielmelli, Paola;
    • Elli, Elena Maria
    Publication type:
    Article
    9

    Impact of bone marrow fibrosis grade in post‐polycythemia vera and post‐essential thrombocythemia myelofibrosis: A study of the MYSEC group.

    Published in:
    American Journal of Hematology, 2020, v. 95, n. 1, p. E1, doi. 10.1002/ajh.25644
    By:
    • Mora, Barbara;
    • Guglielmelli, Paola;
    • Rumi, Elisa;
    • Maffioli, Margherita;
    • Barraco, Daniela;
    • Rambaldi, Alessandro;
    • Caramella, Marianna;
    • Komrokji, Rami S.;
    • Kiladjian, Jean‐Jacques;
    • Gotlib, Jason;
    • Iurlo, Alessandra;
    • Cervantes, Francisco;
    • Devos, Timothy;
    • Palandri, Francesca;
    • De Stefano, Valerio;
    • Ruggeri, Marco;
    • Silver, Richard T.;
    • Albano, Francesco;
    • Benevolo, Giulia;
    • Cavalloni, Chiara
    Publication type:
    Article
    10

    Italian survey on clinical practice in myeloproliferative neoplasms. A GIMEMA Myeloproliferative Neoplasms Working Party initiative.

    Published in:
    American Journal of Hematology, 2019, v. 94, n. 9, p. E239, doi. 10.1002/ajh.25555
    By:
    • Loscocco, Giuseppe G.;
    • Mannelli, Francesco;
    • Guglielmelli, Paola;
    • Paoli, Chiara;
    • Marone, Ilaria;
    • Cucci, Rosalba;
    • Coltro, Giacomo;
    • Sordi, Benedetta;
    • Albano, Francesco;
    • Breccia, Massimo;
    • De Stefano, Valerio;
    • Finazzi, Guido;
    • Iurlo, Alessandra;
    • Martino, Bruno;
    • Palandri, Francesca;
    • Passamonti, Francesco;
    • Siragusa, Sergio;
    • Mannelli, Lara;
    • Fantoni, Duccio;
    • Fazi, Paola
    Publication type:
    Article
    11
    12
    13
    14
    15
    16
    17

    Second primary malignancies in postpolycythemia vera and postessential thrombocythemia myelofibrosis: A study on 2233 patients.

    Published in:
    Cancer Medicine, 2019, v. 8, n. 9, p. 4089, doi. 10.1002/cam4.2107
    By:
    • Mora, Barbara;
    • Rumi, Elisa;
    • Guglielmelli, Paola;
    • Barraco, Daniela;
    • Maffioli, Margherita;
    • Rambaldi, Alessandro;
    • Caramella, Marianna;
    • Komrokji, Rami;
    • Gotlib, Jason;
    • Kiladjian, Jean Jacques;
    • Cervantes, Francisco;
    • Devos, Timothy;
    • Palandri, Francesca;
    • Stefano, Valerio;
    • Ruggeri, Marco;
    • Silver, Richard T.;
    • Benevolo, Giulia;
    • Albano, Francesco;
    • Cavalloni, Chiara;
    • Pietra, Daniela
    Publication type:
    Article
    18

    Determinants of Covid19 disease and of survival after Covid19 in MPN patients treated with ruxolitinib.

    Published in:
    Blood Cancer Journal, 2023, v. 13, n. 1, p. 1, doi. 10.1038/s41408-023-00834-6
    By:
    • Palandri, Francesca;
    • Elli, Elena M.;
    • Auteri, Giuseppe;
    • Bonifacio, Massimiliano;
    • Benevolo, Giulia;
    • Heidel, Florian H.;
    • Paglia, Simona;
    • Trawinska, Malgorzata M.;
    • Bosi, Costanza;
    • Rossi, Elena;
    • Tiribelli, Mario;
    • Tieghi, Alessia;
    • Iurlo, Alessandra;
    • Polverelli, Nicola;
    • Caocci, Giovanni;
    • Binotto, Gianni;
    • Cavazzini, Francesco;
    • Beggiato, Eloise;
    • Cilloni, Daniela;
    • Tatarelli, Caterina
    Publication type:
    Article
    19

    Determinants of Covid19 disease and of survival after Covid19 in MPN patients treated with ruxolitinib.

    Published in:
    2023
    By:
    • Palandri, Francesca;
    • Elli, Elena M.;
    • Auteri, Giuseppe;
    • Bonifacio, Massimiliano;
    • Benevolo, Giulia;
    • Heidel, Florian H.;
    • Paglia, Simona;
    • Trawinska, Malgorzata M.;
    • Bosi, Costanza;
    • Rossi, Elena;
    • Tiribelli, Mario;
    • Tieghi, Alessia;
    • Iurlo, Alessandra;
    • Polverelli, Nicola;
    • Caocci, Giovanni;
    • Binotto, Gianni;
    • Cavazzini, Francesco;
    • Beggiato, Eloise;
    • Cilloni, Daniela;
    • Tatarelli, Caterina
    Publication type:
    Letter
    20

    Long-term follow-up of recovered MPN patients with COVID-19.

    Published in:
    2021
    By:
    • Barbui, Tiziano;
    • Iurlo, Alessandra;
    • Masciulli, Arianna;
    • Carobbio, Alessandra;
    • Ghirardi, Arianna;
    • Rossi, Giuseppe;
    • Harrison, Claire;
    • Alvarez-Larran, Alberto;
    • Elli, Elena Maria;
    • Kiladjian, Jean-Jaques;
    • Gasior Kabat, Mercedes;
    • Marin Sanchez, Alberto;
    • Palandri, Francesca;
    • Andrade-Campos, Marcio Miguel;
    • Vannucchi, Alessandro Maria;
    • Carreno-Tarragona, Gonzalo;
    • Papadopoulos, Petros;
    • Quiroz Cervantes, Keina;
    • Angeles Foncillas, Maria;
    • Fox, Maria Laura
    Publication type:
    Letter to the Editor
    21

    Ruxolitinib discontinuation syndrome: incidence, risk factors, and management in 251 patients with myelofibrosis.

    Published in:
    Blood Cancer Journal, 2021, v. 11, n. 1, p. 1, doi. 10.1038/s41408-020-00392-1
    By:
    • Palandri, Francesca;
    • Palumbo, Giuseppe Alberto;
    • Elli, Elena Maria;
    • Polverelli, Nicola;
    • Benevolo, Giulia;
    • Martino, Bruno;
    • Abruzzese, Elisabetta;
    • Tiribelli, Mario;
    • Tieghi, Alessia;
    • Latagliata, Roberto;
    • Cavazzini, Francesco;
    • Bergamaschi, Micaela;
    • Binotto, Gianni;
    • Crugnola, Monica;
    • Isidori, Alessandro;
    • Caocci, Giovanni;
    • Heidel, Florian;
    • Pugliese, Novella;
    • Bosi, Costanza;
    • Bartoletti, Daniela
    Publication type:
    Article
    22
    23
    24
    25
    26
    27

    Influence of additional cytogenetic abnormalities on the response and survival in late chronic phase chronic myeloid leukemia patients treated with imatinib: long-term results.

    Published in:
    Leukemia & Lymphoma, 2009, v. 50, n. 1, p. 114, doi. 10.1080/10428190802492415
    By:
    • Palandri, Francesca;
    • Testoni, Nicoletta;
    • Luatti, Simona;
    • Marzocchi, Giulia;
    • Baldazzi, Carmen;
    • Stacchini, Monica;
    • Castagnetti, Fausto;
    • Breccia, Massimo;
    • Specchia, Giorgina;
    • Pane, Fabrizio;
    • Saglio, Giuseppe;
    • Martinelli, Giovanni;
    • Baccarani, Michele;
    • Rosti, Gianantonio
    Publication type:
    Article
    28
    29

    PB2198: TRIAL IN PROGRESS: AN OPEN‐LABEL, GLOBAL, MULTICENTER, PHASE 1B/2 STUDY OF TL‐895, A BRUTON’S TYROSINE KINASE INHIBITOR (BTKI), ADDED TO RUXOLITINIB (RUX) IN PATIENTS (PTS) WITH MYELOFIBROSIS (MF)

    Published in:
    HemaSphere, 2023, v. 7, p. 1, doi. 10.1097/01.HS9.0000975544.01102.10
    By:
    • Palandri, Francesca;
    • Gröpper, Stefanie;
    • Loschi, Michael;
    • Bellesso, Marcelo;
    • Grosicki, Sebastian;
    • Giraldo, Pilar;
    • Harrison, Claire;
    • Clevenger, Tracy;
    • Stuart, Nikki;
    • Qamoos, Hope;
    • Vosganian, Gregory;
    • Rothbaum, Wayne P.;
    • Verstovsek, Srdan;
    • Vachhani, Pankit
    Publication type:
    Article
    30
    31
    32

    P1055: BROMODOMAIN AND EXTRA‐TERMINAL (BET) INHIBITOR INCB057643 (LIMBER‐103) IN PATIENTS (PTS) WITH RELAPSED OR REFRACTORY MYELOFIBROSIS (R/R MF) AND OTHER ADVANCED MYELOID NEOPLASMS: A PHASE 1 STUDY.

    Published in:
    HemaSphere, 2023, v. 7, p. 1, doi. 10.1097/01.HS9.0000971116.17929.06
    By:
    • Watts, Justin M.;
    • Hunter, Anthony M.;
    • Iurlo, Alessandra;
    • Xicoy, Blanca;
    • Palandri, Francesca;
    • Reeves, Brandi;
    • Vannucchi, Alessandro;
    • Bose, Prithviraj;
    • Ayala Diaz, Rosa;
    • Halpern, Anna B.;
    • Chen, Xuejun;
    • Seguy, Francis;
    • Zhou, Feng;
    • Zheng, Fred;
    • Vachhani, Pankit
    Publication type:
    Article
    33
    34

    P1038: TL‐895, A FIRST‐IN‐CLASS, COVALENT BRUTON TYROSINE KINASE INHIBITOR (BTKI) FOR THE TREATMENT OF MYELOFIBROSIS (MF) PATIENTS (PTS) WITH SEVERE THROMBOCYTOPENIA (PLATELETS (PLTS) <50 K/UL)

    Published in:
    HemaSphere, 2023, v. 7, p. 1, doi. 10.1097/01.HS9.0000971048.09624.cd
    By:
    • Loschi, Michael;
    • Rejto, Laszlo;
    • Chuah, Hun;
    • Caramella, Marianna;
    • Hernández Rivas, Jesus;
    • Sportoletti, Paolo;
    • Dubruille, Viviane;
    • Bellesso, Marcelo;
    • Gröpper, Stefanie;
    • Crodel, Carl;
    • Qamoos, Hope;
    • Socotch, Ashley;
    • Huang, Zhuying;
    • Wall, Sarah;
    • Mcgreivy, Jesse;
    • Rothbaum, Wayne P.;
    • Verstovsek, Srdan;
    • Palandri, Francesca
    Publication type:
    Article
    35

    P1041: LEUKOCYTOSIS SELECTS A SUBGROUP OF LOW‐RISK PV PATIENTS IN WHOM PHLEBOTOMY‐ALONE MAY BE INSUFFICIENT.

    Published in:
    HemaSphere, 2023, v. 7, p. 1, doi. 10.1097/01.HS9.0000971060.47099.b6
    By:
    • Carobbio, Alessandra;
    • Vannucchi, Alessandro;
    • De Stefano, Valerio;
    • Ghirardi, Arianna;
    • Carioli, Greta;
    • Masciulli, Arianna;
    • Rossi, Elena;
    • Ciceri, Fabio;
    • Bonifacio, Massimiliano;
    • Iurlo, Alessandra;
    • Palandri, Francesca;
    • Benevolo, Giulia;
    • Pane, Fabrizio;
    • Ricco, Alessandra;
    • Carli, Giuseppe;
    • Caramella, Marianna;
    • Rapezzi, Davide;
    • Musolino, Caterina;
    • Siragusa, Sergio;
    • Rumi, Elisa
    Publication type:
    Article
    36

    P1027: UPDATED DURABILITY OF RESPONSE AND SAFETY IN MANIFEST ARM 3: PELABRESIB (CPI‐0610) COMBINED WITH RUXOLITINIB FOR JAK INHIBITOR TREATMENT‐NAÏVE PATIENTS WITH MYELOFIBROSIS.

    Published in:
    HemaSphere, 2023, v. 7, p. 1, doi. 10.1097/01.HS9.0000971004.26914.cb
    By:
    • Harrison, Claire;
    • Patriarca, Andrea;
    • Gupta, Vikas;
    • Palandri, Francesca;
    • Devos, Timothy;
    • Rampal, Raajit K;
    • Talpaz, Moshe;
    • Vannucchi, Alessandro;
    • Kuykendall, Andrew;
    • Kiladjian, Jean‐Jacques;
    • Verstovsek, Srdan;
    • Mesa, Ruben;
    • Colak, Gozde;
    • Dutta, Soumik;
    • Klein, Sandra;
    • Cui, Jie;
    • Chang, Tzuu‐Wang;
    • Mascarenhas, John
    Publication type:
    Article
    37
    38

    P1028: MYELOFIBROSIS (MF) TREATED WITH RUXOLITINIB (RUX) MONOTHERAPY: PREDICTORS OF EARLY DISCONTINUATION AND DEATH ON TREATMENT. THE SHORT-TERM RUX PROGNOSTIC MODEL (STR-PM).

    Published in:
    2023
    By:
    • Palandri, Francesca;
    • Auteri, Giuseppe;
    • Iurlo, Alessandra;
    • Maria Elli, Elena;
    • Paglia, Simona;
    • Bonifacio, Massimiliano;
    • Tiribelli, Mario;
    • Monica Trawinska, Malgorzata;
    • Polverelli, Nicola;
    • Benevolo, Giulia;
    • Tieghi, Alessia;
    • Heidel, Florian;
    • Cavalca, Fabrizio;
    • Caocci, Giovanni;
    • Beggiato, Eloise;
    • Binotto, Gianni;
    • Cavazzini, Francesco;
    • Miglino, Maurizio;
    • Bosi, Costanza;
    • Crugnola, Monica
    Publication type:
    Abstract
    39

    P1022: PHASE 1/2 STUDY OF THE ACTIVIN RECEPTOR-LIKE KINASE 2 (ALK2) INHIBITOR ZILURGISERTIB (INCB000928, LIMBER-104) AS MONOTHERAPY OR WITH RUXOLITINIB IN PATIENTS WITH ANEMIA DUE TO MYELOFIBROSIS.

    Published in:
    2023
    By:
    • Bose, Prithviraj;
    • Mohan, Sanjay;
    • Oh, Stephen;
    • Gotlib, Jason;
    • Ritchie, Ellen;
    • Shimomura, Taizo;
    • Ali, Haris;
    • Boyer, Francoise;
    • Guglielmelli, Paola;
    • Hunter, Anthony M.;
    • Lamothe, Betty;
    • Cui, Yi;
    • Seguy, Francis;
    • Mcbride, Amanda;
    • Palandri, Francesca;
    • Takeuchi, Masahiro;
    • Kiladjian, Jean-Jacques
    Publication type:
    Abstract
    40
    41
    42

    Adherence to ruxolitinib, an oral JAK1/2 inhibitor, in patients with myelofibrosis: interim analysis from an Italian, prospective cohort study (ROMEI).

    Published in:
    Leukemia & Lymphoma, 2022, v. 63, n. 1, p. 189, doi. 10.1080/10428194.2021.1969388
    By:
    • Guglielmelli, Paola;
    • Palandri, Francesca;
    • Selleri, Carmine;
    • Cilloni, Daniela;
    • Mendicino, Francesco;
    • Mazza, Patrizio;
    • Pastore, Domenico;
    • Palumbo, Giuseppe A.;
    • Santoro, Marco;
    • Pavone, Vincenzo;
    • Impera, Stefana;
    • Morelli, Mara;
    • Coco, Paola;
    • Valsecchi, Diletta;
    • Passamonti, Francesco;
    • Breccia, Massimo
    Publication type:
    Article
    43
    44

    Impact of JAK2(V617F) mutation status on treatment response to anagrelide in essential thrombocythemia: an observational, hypothesis-generating study.

    Published in:
    Drug Design, Development & Therapy, 2015, v. 9, p. 2687, doi. 10.2147/DDDT.S79576
    By:
    • Cascavilla, Nicola;
    • De Stefano, Valerio;
    • Pane, Fabrizio;
    • Pancrazzi, Alessandro;
    • Iurlo, Alessandra;
    • Gobbi, Marco;
    • Palandri, Francesca;
    • Specchia, Giorgina;
    • Liberati, A. Marina;
    • D'Adda, Mariella;
    • Gaidano, Gianluca;
    • Fjerza, Rajmonda;
    • Achenbach, Heinrich;
    • Smith, Jonathan;
    • Wilde, Paul;
    • Vannucchi, Alessandro M.
    Publication type:
    Article
    45
    46

    Dosing and clinical outcomes of ruxolitinib in patients with myelofibrosis in a real‐world setting: Interim results of the Italian observational study (ROMEI).

    Published in:
    Cancer (0008543X), 2025, v. 131, n. 7, p. 1, doi. 10.1002/cncr.35801
    By:
    • Breccia, Massimo;
    • Palandri, Francesca;
    • Martelli, Maurizio;
    • Mendicino, Francesco;
    • Malato, Alessandra;
    • Palumbo, Giuseppe A.;
    • Sibilla, Silvia;
    • Di Renzo, Nicola;
    • Abruzzese, Elisabetta;
    • Siragusa, Sergio;
    • Crugnola, Monica;
    • Selleri, Carmine;
    • Pane, Fabrizio;
    • Sportoletti, Paolo;
    • Martino, Bruno;
    • Impera, Stefana;
    • Ricco, Alessandra;
    • Langella, Maria;
    • Ditonno, Paolo;
    • Carli, Giuseppe
    Publication type:
    Article
    47

    Clinical outcomes of ruxolitinib treatment in 595 intermediate‐1 risk patients with myelofibrosis: The RUX‐MF Real‐World Study.

    Published in:
    Cancer (0008543X), 2024, v. 130, n. 24, p. 4257, doi. 10.1002/cncr.35489
    By:
    • Palandri, Francesca;
    • Elli, Elena M.;
    • Morsia, Erika;
    • Benevolo, Giulia;
    • Tiribelli, Mario;
    • Beggiato, Eloise;
    • Bonifacio, Massimiliano;
    • Farina, Mirko;
    • Martino, Bruno;
    • Caocci, Giovanni;
    • Pugliese, Novella;
    • Tieghi, Alessia;
    • Crugnola, Monica;
    • Binotto, Gianni;
    • Cavazzini, Francesco;
    • Abruzzese, Elisabetta;
    • Iurlo, Alessandra;
    • Isidori, Alessandro;
    • Bosi, Costanza;
    • Guglielmana, Veronica
    Publication type:
    Article
    48

    Incidence of blast phase in myelofibrosis patients according to anemia severity at ruxolitinib start and during therapy.

    Published in:
    Cancer (0008543X), 2024, v. 130, n. 8, p. 1270, doi. 10.1002/cncr.35156
    By:
    • Palandri, Francesca;
    • Palumbo, Giuseppe A.;
    • Benevolo, Giulia;
    • Iurlo, Alessandra;
    • Elli, Elena M.;
    • Abruzzese, Elisabetta;
    • Polverelli, Nicola;
    • Tiribelli, Mario;
    • Auteri, Giuseppe;
    • Tieghi, Alessia;
    • Caocci, Giovanni;
    • Binotto, Gianni;
    • Cavazzini, Francesco;
    • Branzanti, Filippo;
    • Beggiato, Eloise;
    • Miglino, Maurizio;
    • Bosi, Costanza;
    • Crugnola, Monica;
    • Bocchia, Monica;
    • Martino, Bruno
    Publication type:
    Article
    49

    Ruxolitinib in cytopenic myelofibrosis: Response, toxicity, drug discontinuation, and outcome.

    Published in:
    Cancer (0008543X), 2023, v. 129, n. 11, p. 1704, doi. 10.1002/cncr.34722
    By:
    • Palandri, Francesca;
    • Breccia, Massimo;
    • Mazzoni, Camilla;
    • Auteri, Giuseppe;
    • Elli, Elena Maria;
    • Trawinska, Malgorzata M.;
    • Polverelli, Nicola;
    • Tiribelli, Mario;
    • Benevolo, Giulia;
    • Iurlo, Alessandra;
    • Tieghi, Alessia;
    • Heidel, Florian H.;
    • Caocci, Giovanni;
    • Beggiato, Eloise;
    • Binotto, Gianni;
    • Cavazzini, Francesco;
    • Miglino, Maurizio;
    • Bosi, Costanza;
    • Crugnola, Monica;
    • Bocchia, Monica
    Publication type:
    Article
    50

    Peripheral blasts are associated with responses to ruxolitinib and outcomes in patients with chronic‐phase myelofibrosis.

    Published in:
    Cancer (0008543X), 2022, v. 128, n. 13, p. 2449, doi. 10.1002/cncr.34216
    By:
    • Palandri, Francesca;
    • Bartoletti, Daniela;
    • Iurlo, Alessandra;
    • Bonifacio, Massimiliano;
    • Abruzzese, Elisabetta;
    • Caocci, Giovanni;
    • Elli, Elena M.;
    • Auteri, Giuseppe;
    • Tiribelli, Mario;
    • Polverelli, Nicola;
    • Miglino, Maurizio;
    • Heidel, Florian H.;
    • Tieghi, Alessia;
    • Benevolo, Giulia;
    • Beggiato, Eloise;
    • Fava, Carmen;
    • Cavazzini, Francesco;
    • Pugliese, Novella;
    • Binotto, Gianni;
    • Bosi, Costanza
    Publication type:
    Article